Bloomberg Opinion writers have explored what it means to suddenly have a long-held constitutional right taken away. Here are some highlights:
• The US Food and Drug Administration’s new rule to make drugs used to induce abortion in early pregnancy more easily accessible is a step in the right direction, but too cautious: “The FDA should have gone further and having to drop the unnecessary hurdles complicate the efforts of pharmacies to deliver the medication.” —Sarah Green Carmichael
• The Dobbs ruling is more evidence of an increasingly politicized Supreme Court and the legacy of Donald Trump’s divisive administration: the conservative court follows “a game plan to turn back the clock to an era when personal liberty depended on the state in which you lived. —Noah Veldman
• Economist Caitlin Myers discusses the lasting, damaging consequences of allowing the government to determine when a woman becomes a mother. “If they use abortion to prevent an unwanted birth, what happens? They earn more, they avoid poverty – and not only for themselves, but also for the children they will have later.” — Clara F. Marques
• Voter outrage over the loss of abortion rights for women helped Democrats fend off a red wave in November. Now they look to key battlefield states that can help them exploit the problem in the general election, when the stakes are even higher: “In 2024, they will defend not only with the White House, but also with 23 Senate seats.” — Juliana Goldman
• Policymakers in states where abortion remains legal should broaden access to the procedure: “Why do we rely so heavily on abortion clinics? Why can’t doctors’ offices and hospitals take more of the burden?” —Sarah Green Carmichael
This column does not necessarily reflect the views of the editors or Bloomberg LP and its owners.
Bloomberg Opinion provides commentary on business, economics, politics, technology and markets.
More stories like this are available at bloomberg.com/opinion